- | Expert Commentary Expert Commentary
FDA Needs Modernization, Not More $$ | InsideSources
- | Expert Commentary Expert Commentary
Can the FDA Regulate Away the Perils of Outdoor Crops? | The Hill
- | Expert Commentary Expert Commentary
Nutrition Policy Without Politics | The Eagle-Tribune
- | Expert Commentary Expert Commentary
Nutrition Science Moves On
- | Radio Appearance Radio Appearance
Veronique de Rugy on The John Batchelor Show - Infrastructure and Paid Leave (Part 2)
Veronique de Rugy explains why Nordic paid leave programs tend to benefit middle- and upper-class workers, not the low-income
- | Expert Commentary Expert Commentary
The FDA's Slippery Slope Toward Mandating Raw Broccoli for Breakfast
The FDA's proposed tobacco regulations would make smokers poorer, less healthy, and less free. Read more at Creators.
- | Expert Commentary Expert Commentary
The FDA Should Embrace Remote and Automated Drug Inspection Technology
The FDA's committment to on-site inspections is causing the U.S. to fall behind. Read more at STAT.
- | Expert Commentary Expert Commentary
EU's 'Farm to Fork' Demands Could Mean Indigestion for US Food Exporters
Europe's Farm to Fork program is supposedly about healthier food and better labeling, but it might be protectionism in disguise
- | Healthcare Healthcare
- | Expert Commentary Expert Commentary
Seniors Suffer the Most From Antiquated FDA Approval Process
The FDA's risk aversion costs lives, but the Japanese process for drug approval offers a solution. Read more at The Hill.
- | Regulation Regulation
- | Expert Commentary Expert Commentary
Get the 'F' out of the FDA
Patrick McLaughlin and Trace Mitchell look at alternatives to the FDA managing food safety regulations.Read more in the Hill.
- | Expert Commentary Expert Commentary
US Remains Vulnerable to COVID-19 Scams
As states and hospitals scour the world for urgently needed COVID-19 supplies, Food and Drug Administration (FDA) efforts to
- | Expert Commentary Expert Commentary
COVID-19 Failures Show Why the CDC and FDA Should Be More Independent
When agencies rely on politicians for funding and support, their decisions tend to be politicized. Read more at Discourse.
- | Healthcare Healthcare
- | Policy Briefs Policy Briefs
Running ahead of Pandemics: Achieving In-Advance Antiviral Drugs
Three months into the COVID-19 outbreak caused by a novel strain of coronavirus (SARS-CoV-2), the world is still in search of an
- | Expert Commentary Expert Commentary
FDA Is Slowing Down Production of Hand Sanitizers
With hand sanitizer in short supply and alcohol distilleries ready to step up, the famously risk-averse FDA's excessive
- | Healthcare Healthcare
- | Policy Briefs Policy Briefs
FDA Drug Review Reforms
The High Cost of Current FDA Drug Review PoliciesOn average, it takes 466 days for a new drug to be approved for marketing by
- | Healthcare Healthcare
- | Expert Commentary Expert Commentary
Regulators Wonder if Cancer Patients ‘Need’ New Treatments
Matthew D. Mitchell and Anna Parsons write on regulatory hurdles faced in introducing a new cancer drug, despite the drug
- | Regulation Regulation
- | Expert Commentary Expert Commentary
The FDA Created Illegal and Dangerous Vapes
Veronique de Rugy explains how FDA policies led to the creation of dangerous black-market e-cigarette cartridges which have
- | Healthcare Healthcare
- | Working Papers Working Papers
Regulatory Review Time and Pharmaceutical R&D
Published in Health Economics, October 19, 2020.When making investment decisions, drug manufacturers must take into account a
- | Healthcare Healthcare
- | Expert Commentary Expert Commentary
Let Surgeons Do Surgery
American healthcare providers are facing a care crisis of their own: they’re burned out. Whether it’s due to paperwork
